-
September 19, 2018 16:00 KST
- 175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis
- Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented b...
-
September 19, 2018 09:00 KST
- Aspect Biosystems Announces Liver Tissue Collaboration with JSR
- Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting ...
-
September 18, 2018 15:55 KST
- THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
- On August 31st the NUVISAN GROUP, one of Europe´s leading CRO´s focused on early stage drug development for th...
-
September 17, 2018 22:05 KST
- MEDTEX: Foresee the Next Wave of Healthcare Revolution
- Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in glob...
-
September 17, 2018 18:15 KST
- Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice[1]
- For media excluding the United States of America, Canada and the United Kingdom
Boehringer Ingelheim announ...
-
September 17, 2018 10:15 KST
- Clinical trial data for nintedanib in patients with advanced IPF published
- Results from the INSTAGE® trial have been presented at the 2018 European Respiratory Society (ERS) conference ...
-
September 17, 2018 10:05 KST
- New study results provide evidence that Ofev® (nintedanib) slows progression of IPF beyond four years with consistent safety
- Results from INPULSIS®-ON, published today in Lancet Respiratory Medicine, provide insights into the long-term...
-
September 14, 2018 16:00 KST
- ResMed Introduces Its First Minimal-contact Full Face CPAP Mask, AirFit F30
- ResMed (NYSE: RMD) (ASX: RMD) today introduced its first minimal-contact full face CPAP mask, AirFit F30, the ...
-
September 14, 2018 15:00 KST
- Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare
- Today, Acelity announced an agreement to sell its advanced wound dressings manufacturing facility located in G...
-
September 13, 2018 18:25 KST
- Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
- Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical ...
-
September 13, 2018 17:30 KST
- OptraSCAN® Receives CE Mark Approval for In-Vitro Diagnostics Use
- OptraSCAN®, the leading end-to-end digital pathology solution provider, today announced that their whole-slide...
-
September 13, 2018 10:10 KST
- OTEZLA® (Apremilast) Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis Beyond Those Captured by Assessing Skin Alone
- Celgene Corporation (NASDAQ:CELG) today announced the results of two post hoc sub-analyses of clinical trials ...
-
September 10, 2018 22:05 KST
- dClinic(DHC) Phase 1 - Over 50% SOLD in first 10 days
- “Current Blockchains are not dedicated Healthcare blockchains. They are not purpose built to handle fractal cl...
-
September 07, 2018 09:45 KST
- Swiss Advanced Vision Launches Harmonis - The First Customizable EDOF IOL for Cataract Surgery
- Swiss Advanced Vision (SAV-IOL) has announced the launch of Harmonis, a customizable intraocular lens (IOL) wi...
-
September 06, 2018 14:40 KST
- JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reductio...
-
September 06, 2018 10:50 KST
- New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy, Noninvasive Masimo PVi® and Invasive Esophageal Doppler
- Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in whic...
-
September 05, 2018 10:15 KST
- Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
- Boehringer Ingelheim and Tsinghua University in Beijing announce a collaboration aiming to research and develo...
-
September 03, 2018 13:45 KST
- GNT Pharma's Ropesalazine Effective in Treating Dog Dementia
- GNT Pharma said Ropesalazine, a drug candidate for Alzheimer’s disease (AD), has shown an outstanding benefici...
-
September 03, 2018 11:40 KST
- ResMed Files Patent Infringement Action against Fisher & Paykel
- ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical device company and innovator in sleep a...
-
August 31, 2018 11:55 KST
- Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
- Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 ...
-
August 31, 2018 10:50 KST
- Ferring and Celmatix Launch Ambitious Genomics Collaboration to Advance Care in Reproductive Medicine and Women’s Health
- Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering n...
-
August 28, 2018 14:00 KST
- ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.
- ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced ke...
-
August 28, 2018 11:25 KST
- New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During Moderate Hyperoxia
- Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in ...
-
August 27, 2018 16:10 KST
- GN Hearing Introduces New Interton Ready™ Hearing Aid with Excellent Connectivity and Personalized Sound at a Compelling Price
- GN Hearing, one of the world’s leading hearing aid manufacturers and the pioneer of 2.4 GHz wireless connectiv...
-
August 23, 2018 11:30 KST
- 22nd Century Receives Order for 3.6 Million SPECTRUM® U.S. Government Research Cigarettes
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reductio...
-
August 20, 2018 17:05 KST
- Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)
- Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCI™ trial and GL...
-
August 17, 2018 10:45 KST
- GN Hearing and Google Announce Partnership to Bring Direct Mobile Streaming from Android Devices to Hearing Aids
- GN Hearing and Google have today announced a new technology partnership that will make GN Hearing the first ma...
-
August 15, 2018 22:05 KST
- 2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine
- From November 29th to December 2nd 2018, global-leading biomedical and technology institutes will gather in Ta...
-
August 14, 2018 11:00 KST
- New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse Oximetry to Screen Children with Down Syndrome for Risk of Obstructive Sleep Apnea Prior to Diagnostic Multichannel Sleep Studies
- Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investig...
-
August 14, 2018 09:45 KST
- GN Hearing Announces Unprecedented Layers of Sound™ and the World’s Most Advanced Rechargeable Hearing Aid Solution
- GN Hearing today unveils the world’s first Premium-Plus hearing aid: ReSound LiNX Quattro™, designed for peopl...
-
August 10, 2018 14:00 KST
- Merz Creates Americas Region, Expands Bob Rhatigan’s Leadership Role
- Merz, a global leader in medical aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan a...
-
August 06, 2018 17:40 KST
- Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
- Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium (GTC)—consisting of Imperial College Lond...
-
August 03, 2018 11:35 KST
- Graminex® LLC successfully challenges Serelys’ patents for use of pollen extracts in treating women's PMS and menopausal symptoms
- Graminex® LLC is pleased to announce the US Patent Office has rejected Serelys’ patents for use of its pollen ...
-
August 02, 2018 18:50 KST
- Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa
- Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced recently the launch of th...
-
August 01, 2018 17:00 KST
- Takeda Reports First Quarter FY2018 Results
- Takeda Pharmaceutical Company Limited (TOKYO:4502):
Underlying Revenue growth +6.4% with growth in every re...
-
July 31, 2018 14:00 KST
- Impossible Foods Launches in Macau, China’s Tourist Hotspot
- Impossible Foods is launching its award-winning, plant-based meat in Macau at one of the world’s hottest enter...
-
July 30, 2018 11:35 KST
- KOHI concluded final course of ‘Multi-year Competency enhancement of Diagnosis and Treatment of ASD for Children for Bangladesh’
- Korea Human Resource Development Institute for Health and Welfare(KOHI) announced that it had successfully fin...
-
July 26, 2018 13:45 KST
- Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib in Patients with ALK+ Advanced NSCLC Who are ALK Inhibitor Naïve
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the global, randomized, Phase 3 ALTA-1L...
-
July 25, 2018 15:35 KST
- Banyan Biomarkers Announces Publication of ALERT-TBI Clinical Study Results in The Lancet Neurology
- Banyan Biomarkers, Inc., a pioneer in developing biomarkers for traumatic brain injury (TBI), today announced ...
-
July 24, 2018 09:05 KST
- Ferring’s Heat-Stable Carbetocin Could Save Thousands of Women’s Lives by Preventing Excessive Bleeding after Childbirth
- Ferring Pharmaceuticals today announced new data demonstrating that its heat-stable formulation of carbetocin ...
-
July 20, 2018 10:10 KST
- Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint
- CARMELINA®1 (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 di...
-
July 19, 2018 18:40 KST
- New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
- Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) today announced top-line results from the VISIBLE ...
-
July 19, 2018 17:25 KST
- Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease
- VIEW E-MEDIA KIT (http://bit.ly/2zUquOI) - Emmaus Life Sciences, Inc. (Emmaus) announced today that the New En...
-
July 18, 2018 16:15 KST
- 22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan
- 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm ...
-
July 17, 2018 12:00 KST
- New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery
- Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Kocae...
-
July 13, 2018 16:20 KST
- ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers
- ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Ver...
-
July 13, 2018 13:25 KST
- Dr. Yu-mi Jung of Magic Kiss Dental Clinic, Patented for orthodontic technique to improve gummy smile
- Dr. Yu-mi Jung of Magic Kiss Dental Clinic acquired a patent for the technique to improve gummy smile and corr...
-
July 12, 2018 18:00 KST
- Phase 3 Trial of NINLARO® (ixazomib) as Maintenance Therapy Met Primary Endpoint Demonstrating Statistically Significant Improvement in Progression-Free Survival in Patients with Multiple Myeloma Post-Transplant
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the randomized, Phase 3 TOURMALINE-MM3 ...
-
July 12, 2018 16:15 KST
- EUSA Pharma: NICE Approves the Targeted Cancer Immunotherapy, QARZIBA®▼ (dinutuximab beta) to Treat Children with High-Risk Neuroblastoma
- EUSA Pharma today welcomed a decision by the National Institute for Health and Care Excellence (NICE) to recom...
-
July 11, 2018 17:20 KST
- President Clinton to Deliver Closing Keynote Address on Eliminating Preventable Deaths in Hospitals at the 7th Annual World Patient Safety, Science & Technology Summit
- For the seventh year in a row, U.S. President Bill Clinton will address healthcare leaders and deliver the clo...
-
July 11, 2018 10:50 KST
- Takeda Receives Clearance from the United States Federal Trade Commission for the Proposed Acquisition of Shire plc
- Takeda Pharmaceutical Company Limited:
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, D...
-
July 10, 2018 17:35 KST
- Boehringer Ingelheim Invests More Than €200 Million to Establish Strategic Production Center for Veterinary Public Health in France
- Boehringer Ingelheim today announced an investment of more than €200 million into a new strategic production c...
-
July 10, 2018 11:05 KST
- Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a pha...
-
July 06, 2018 14:00 KST
- Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield™
- Morinaga Milk Industry Co., Ltd., (TOKYO:2264) today announced it has attained self-affirmed GRAS (generally r...
-
July 03, 2018 18:50 KST
- New Analysis of Rekovelle® Data Further Supports Use of AMH to Personalise Fertility Treatment
- Ferring Pharmaceuticals announced today a new analysis* of data from the Phase 3 ESTHER-1 trial[1] showing tha...
-
July 03, 2018 17:05 KST
- Takeda Global Headquarters Grand Opening
- Takeda Pharmaceutical Company Limited, (“Takeda”) (TOKYO:4502) today held the grand opening of Takeda Global H...
-
July 02, 2018 17:55 KST
- CHMP issues positive opinion to expand Jardiance®, Synjardy® and Glyxambi® labels to include positive effects on cardiovascular and renal outcomes
- Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (...
-
July 02, 2018 17:25 KST
- New Study Investigates the Utility of Masimo ORi™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation
- Masimo (NASDAQ: MASI) announced today the findings of a study in which researchers evaluated the ability of Ma...
-
July 02, 2018 10:00 KST
- Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases
- Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive optio...
-
June 29, 2018 17:30 KST
- World Scleroderma Day 2018: Families open up about supporting a loved one with scleroderma, in new video series
- Boehringer Ingelheim today reveals a new collection of unique, personal stories and portraits from family memb...
-
June 27, 2018 17:25 KST
- New patient survey reveals: For people with atrial fibrillation, reversal of their blood thinning treatment is highly important
- Results from a survey in five countries among 902 people living with atrial fibrillation (AF) reinforce the im...
-
June 27, 2018 16:00 KST
- United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™
- Masimo (NASDAQ: MASI) announced today that the United Arab Emirates (UAE) Ministry of Health & Prevention (MOH...
-
June 27, 2018 14:00 KST
- 22nd Century Announces New Non-GMO, Very Low Nicotine Flue-Cured and Burley Tobacco Varieties
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm...
-
June 26, 2018 09:25 KST
- Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that both randomised controlled tri...
-
June 25, 2018 10:00 KST
- Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
- Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (...
-
June 19, 2018 13:45 KST
- Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A
- Octapharma announced today that the European Medicines Agency (EMA) has approved an extension of marketing aut...
-
June 15, 2018 13:25 KST
- Brightree Announces eReferral Integration with athenahealth
- Brightree, the leading provider of cloud-based software helping post-acute care companies improve business per...
-
June 12, 2018 14:45 KST
- New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which r...
-
June 11, 2018 10:25 KST
- Takeda Announces Term Loan Credit Agreement and Amendment to Bridge Credit Agreement in Connection with Proposed Shire Acquisition
- Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) announces that it has today entered into a term l...
-
June 08, 2018 10:55 KST
- Impossible Foods Checks in to Hong Kong Hotels
- Impossible Foods is offering its award-winning, plant-based meat at three of Hong Kong’s top-ranking hotels: H...
-
June 07, 2018 15:15 KST
- Sonion and Valencell Partner to Make Biometrics Universal in Hearables and Hearing Health Markets
- Sonion, the global leader in micro acoustic and micro mechanical technologies and solutions for hearing instru...
-
June 06, 2018 12:40 KST
- Nerviano Medical Sciences Announces Collaboration and License Agreement with Merck to Discover Small Molecule Inhibitors of Certain Anticancer Targets
- Today Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy and one of the leading oncol...
-
June 05, 2018 14:00 KST
- New ResMed-sponsored Study Shows Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination
- A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP)...
-
June 05, 2018 11:50 KST
- New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
- Masimo (NASDAQ:MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which re...
-
June 04, 2018 14:00 KST
- Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab Plus Chemotherapy in Patients with Previously Untreated Follicular Lymphoma to be Presented at ASCO 2018
- Celgene Corporation (NASDAQ:CELG) today announced additional results from RELEVANCE, a phase III, randomized, ...
